H22954, a novel long non-coding RNA down-regulated in AML, inhibits cancer growth in a BCL-2-dependent mechanism

Xiaofei Qi1, Yang Jiao2, Chao Cheng3

  • 1Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Suzhou, 215000, China; Departments of Urology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China; Departments of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.

Cancer Letters
|April 9, 2019
PubMed

Insights

A novel long non-coding RNA, H22954, is downregulated in acute myeloid leukemia (AML). Its restoration inhibits AML cell proliferation and tumor growth by targeting BCL2, suggesting therapeutic potential.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Long non-coding RNAs (lncRNAs) play crucial roles in cancer biology.
  • Identifying novel molecular players in acute myeloid leukemia (AML) is essential for understanding pathogenesis and developing treatments.

Purpose of the Study:

  • To identify and characterize novel lncRNAs involved in AML.
  • To investigate the functional role of the identified lncRNA, H22954, in AML progression.
  • To elucidate the molecular mechanism by which H22954 affects AML cells.

Main Methods:

  • Differential gene expression analysis in CD34+ hematopoietic cells.
  • In vitro studies using cultured AML cells and in vivo mouse xenograft models.
  • Bioinformatic analysis, RNA antisense purification, and luciferase assays to determine molecular targets and mechanisms.
  • Correlation analysis of H22954 expression with clinical parameters in AML patients.

Main Results:

  • A novel lncRNA, H22954, was identified and found to be downregulated in AML patients.
  • H22954 expression inhibited AML cell proliferation and tumor growth in preclinical models.
  • H22954 was shown to target the 3' untranslated region of the BCL2 gene, inhibiting BCL2 expression.
  • Overexpression of H22954 reduced BCL-2 protein levels, promoted cell death, and correlated inversely with disease severity and poor prognosis in AML patients.

Conclusions:

  • H22954 acts as a novel regulator of BCL-2 in acute myeloid leukemia.
  • Reduced H22954 expression is implicated in the pathogenesis of AML.
  • H22954 represents a potential therapeutic target for AML treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
SN2 Reaction: Mechanism02:27

SN2 Reaction: Mechanism

The kinetic studies of SN2 reactions suggest an essential feature of its mechanism: it is a single-step process without intermediates. Here, both the nucleophile and the substrate participate in the rate-determining step.
The presence of the more electronegative halogen in the substrate creates a polarized carbon-halide bond. The halide pulls the electron cloud generating an electrophilic center at the carbon atom. Thus, the carbon atom carries a partial positive charge while the halide has a...
17.2K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
25.8K
Radical Chain-Growth Polymerization: Mechanism01:09

Radical Chain-Growth Polymerization: Mechanism

The radical chain-growth polymerization mechanism consists of three steps: initiation, propagation, and termination of polymerization. The polymerization initiates when a free radical generated from the radical initiator adds to the unsaturated bond in the monomer. The unpaired electron of the free radical and one π electron in the unsaturated bond creates a σ bond between the free radical and the monomer. As a result, the other π electron in the unsaturated bond converts this species into...
3.4K
Anionic Chain-Growth Polymerization: Mechanism01:04

Anionic Chain-Growth Polymerization: Mechanism

The mechanism for anionic chain-growth polymerization involves initiation, propagation, and termination steps. In the initiation step, a nucleophilic anion, such as butyl lithium, initiates the polymerization process by attacking the π bond of the vinylic monomer. As a result, a carbanion, stabilized by the electron‐withdrawing group, is generated. The resulting carbanion acts as a Michael donor in the propagation step and attacks the second vinylic monomer, which acts as a Michael...
2.5K